moclobemide has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moclobemide cotreatment resulted in normalization of the HPA axis response, whereas the HPA system hyperresponse was maintained with steroids alone (AUC-Cort on day 30, 85." | 2.70 | Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. ( Grasser, A; Holsboer, F; Kümpfel, T; Rupprecht, R; Then Bergh, F; Trenkwalder, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Then Bergh, F | 1 |
| Kümpfel, T | 1 |
| Grasser, A | 1 |
| Rupprecht, R | 1 |
| Holsboer, F | 1 |
| Trenkwalder, C | 1 |
1 trial available for moclobemide and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
Topics: Adrenal Cortex Hormones; Adult; Antidepressive Agents; Disability Evaluation; Double-Blind Method; D | 2001 |